Genky Drug Stores Co (TSE:9267) ROCE %: 10.75% (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Genky Drug Stores Co Ltd TSE:9267

82 GF Score

Price 円3,665.00

GF Value 円3,791.60

Valuation Fairly Valued

2 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Genky Drug Stores Co ROCE %?

Genky Drug Stores Co TSE:9267 +3.24% 82 ROCE % is 10.75% as of Mar. 2026. GuruFocus rates TSE:9267 with a GF Score™ of 82/100 and a GF Value™ of 円3,791.60 (Fairly Valued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genky Drug Stores Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.75%.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Genky Drug Stores Co (TSE:9267) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genky Drug Stores Co ROCE % Related Terms

Genky Drug Stores Co ROCE % Historical Data

* Premium members only.

The historical data trend for Genky Drug Stores Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genky Drug Stores Co ROCE % Chart

Genky Drug Stores Co Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Jun26

ROCE %

Get a 7-Day Free Trial

10.62

10.82

12.82

12.92

12.78

Genky Drug Stores Co Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
ROCE %	Get a 7-Day Free Trial															14.21	14.29	13.66	10.75	13.20

82GF Score

Genky Drug Stores Co Ltd TSE:9267

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Genky Drug Stores Co ROCE % Calculation

Genky Drug Stores Co's annualized ROCE % for the fiscal year that ended in Jun. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2026 )		(A: Jun. 2025 )		(A: Jun. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2026 )		(A: Jun. 2025 )		(A: Jun. 2026 )
	=	11466	/	( ( (127326 - 43812)	+	(145598 - 49709) )	/ 2 )
	=	11466	/	( (83514	+	95889)	/ 2 )
	=	11466	/	89701.5
	=	12.78 %

Genky Drug Stores Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	9616	/	( ( (134420 - 47207)	+	(142340 - 50638) )	/ 2 )
	=	9616	/	( ( 87213	+	91702 )	/ 2 )
	=	9616	/	89457.5
	=	10.75 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 10.75% mean?

Genky Drug Stores Co (TSE:9267) has a ROCE % of 10.75% as of Mar. 2026.

Is Genky Drug Stores Co's ROCE % too high?

Genky Drug Stores Co's current ROCE % is 10.75%. The Healthcare Providers & Services industry median ROCE % is 6.53. Genky Drug Stores Co's value of 10.75% is 64.6% above this industry median. Overall, Genky Drug Stores Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Genky Drug Stores Co's ROCE % compare to competitors?

Genky Drug Stores Co's ROCE % of 10.75% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.53. Genky Drug Stores Co's value of 10.75% is 64.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.53, based on 647 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genky Drug Stores Co's current ROCE % of 10.75% is 64.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genky Drug Stores Co's current ROCE % is 10.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Genky Drug Stores Co stock overvalued right now?

Based on GuruFocus' analysis, Genky Drug Stores Co (TSE:9267) is currently considered Fairly Valued. The stock's GF Value™ is 円3,791.60, compared to a current price of 円3,665.00 — trading 3.3% below its estimated fair value. The current ROCE % is 10.75% and 64.6% above the Healthcare Providers & Services industry median of 6.53. Genky Drug Stores Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Genky Drug Stores Co (TSE:9267), the current ROCE % is 10.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genky Drug Stores Co (TSE:9267) Overvalued in 2026?

Based on GuruFocus' analysis, Genky Drug Stores Co stock appears to be undervalued. The current stock price of 円3,665.00 is trading 3.3% below its estimated GF Value™ of 円3,791.60. GuruFocus considers Genky Drug Stores Co to be Fairly Valued.

Key valuation signals for TSE:9267:

ROCE %: 10.75%
GF Value™: 円3,791.60 vs. price of 円3,665.00 (3.3% below fair value)
GF Score™: 82/100 with 2 warning signs
Industry Position: 64.6% above the Healthcare Providers & Services median

No single metric tells the full story. See the TSE:9267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →